(Reuters) - TRENTON, N.J., April 13 - New Jersey Gov. Jon Corzine was heavily sedated and breathing with the help of a ventilator on Friday after a highway accident, though his condition was improving, aides and doctors said.
The Democratic governor was listed in critical but stable condition following the Thursday night crash in which he broke his left leg, six ribs, his sternum and collarbone.
Read more at Reuters.com Bonds News
Friday, April 13, 2007
Cott, Dyax, FCStone, Sallie Mae, Semitool, Xpress: U.S. Equity Movers
(Bloomberg) -- The following is a list of companies whose shares are having unusual price changes in U.S. exchanges today. Stock symbols are in parentheses after company names. Share prices are as of 2:40 p.m. New York time.
Avalon Pharmaceuticals Inc. (AVRX US) rose 57 cents, or 12 percent, to $5.19 and traded as high as $5.25. Shares of the drugmaker may rise more than 180 percent in a year on the promise of a drug in early-stage trials, Business Week reported in its ``Inside Wall Street'' column, citing Patrick Flanigan of WR Hambrecht & Co. Flanigan said the drug AVN944, designed to inhibit tumor-cell growth, could have peak sales of $550 million, according to the magazine.
Read more at Bloomberg Stocks News
Avalon Pharmaceuticals Inc. (AVRX US) rose 57 cents, or 12 percent, to $5.19 and traded as high as $5.25. Shares of the drugmaker may rise more than 180 percent in a year on the promise of a drug in early-stage trials, Business Week reported in its ``Inside Wall Street'' column, citing Patrick Flanigan of WR Hambrecht & Co. Flanigan said the drug AVN944, designed to inhibit tumor-cell growth, could have peak sales of $550 million, according to the magazine.
Read more at Bloomberg Stocks News
No Survivors Are Expected in Capsizing of Rig-Service Vessel in North Sea
(Bloomberg) -- The U.K. navy resumed a search for five Norwegians missing from a boat that capsized yesterday in the North Sea and may be trapped inside the vessel. The U.K. coastguard said they are unlikely to be found alive.
Three out of the 15 Norwegians on board the Bourbon Dolphin are already confirmed dead, said Matthieu Pirouelle, a Paris- based spokesman for shipowner Bourbon SA, the world's largest owner of supply vessels for deepwater oil exploration. Divers are now at the capsized boat, Michael Mulford, a spokesman for the U.K. air force, said by phone from Kinloss, Scotland.
Read more at Bloomberg Energy News
Three out of the 15 Norwegians on board the Bourbon Dolphin are already confirmed dead, said Matthieu Pirouelle, a Paris- based spokesman for shipowner Bourbon SA, the world's largest owner of supply vessels for deepwater oil exploration. Divers are now at the capsized boat, Michael Mulford, a spokesman for the U.K. air force, said by phone from Kinloss, Scotland.
Read more at Bloomberg Energy News
Icahn: Motorola should fix problems before buyback
(Reuters) - The activist shareholder, who seeks a seat on Motorola's board, had previously only urged the company to increase its share repurchase program to boost shareholder value.
But he now says other matters take precedence.
Read more at Reuters.com Business News
But he now says other matters take precedence.
Read more at Reuters.com Business News
Dyax, Irwin Financial, Sallie Mae, Semitool, Ventana: U.S. Equity Movers
(Bloomberg) -- The following is a list of companies whose shares are having unusual price changes in U.S. exchanges today. Stock symbols are in parentheses after company names. Share prices are as of 1:10 p.m. New York time.
Avalon Pharmaceuticals Inc. (AVRX US) rose 54 cents, or 12 percent, to $5.16 and traded as high as $5.25. Shares of the drugmaker may rise more than 180 percent in a year on the promise of a drug in early-stage trials, Business Week reported in its ``Inside Wall Street'' column, citing Patrick Flanigan of WR Hambrecht & Co. Flanigan said the drug AVN944, designed to inhibit tumor-cell growth, could have peak sales of $550 million, according to the magazine.
Read more at Bloomberg Stocks News
Avalon Pharmaceuticals Inc. (AVRX US) rose 54 cents, or 12 percent, to $5.16 and traded as high as $5.25. Shares of the drugmaker may rise more than 180 percent in a year on the promise of a drug in early-stage trials, Business Week reported in its ``Inside Wall Street'' column, citing Patrick Flanigan of WR Hambrecht & Co. Flanigan said the drug AVN944, designed to inhibit tumor-cell growth, could have peak sales of $550 million, according to the magazine.
Read more at Bloomberg Stocks News
NJ governor on ventilator but stable after crash
(Reuters) - The Democratic governor was listed in critical but stable condition following the Thursday night highway accident in which he broke his left leg and several ribs.
Corzine, who was a passenger in the front of a police sport utility vehicle when it swerved to avoid another car, was not wearing a seat belt as mandated by state law.
Read more at Reuters.com Bonds News
Corzine, who was a passenger in the front of a police sport utility vehicle when it swerved to avoid another car, was not wearing a seat belt as mandated by state law.
Read more at Reuters.com Bonds News
RBS, Fortis and Santander move in on ABN -source
(Reuters) - Fortis, RBS, Santander were not available for comment. ABN declined to comment.
Read more at Reuters.com Bonds News
Read more at Reuters.com Bonds News
Subscribe to:
Posts (Atom)
